ENJUVIA Drug Patent Profile
✉ Email this page to a colleague
When do Enjuvia patents expire, and when can generic versions of Enjuvia launch?
Enjuvia is a drug marketed by Aspen and is included in one NDA.
The generic ingredient in ENJUVIA is estrogens, conjugated synthetic b. There are three drug master file entries for this compound. Additional details are available on the estrogens, conjugated synthetic b profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ENJUVIA?
- What are the global sales for ENJUVIA?
- What is Average Wholesale Price for ENJUVIA?
Summary for ENJUVIA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Clinical Trials: | 2 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ENJUVIA |
What excipients (inactive ingredients) are in ENJUVIA? | ENJUVIA excipients list |
DailyMed Link: | ENJUVIA at DailyMed |
![ENJUVIA drug patent expirations Drug patent expirations by year for ENJUVIA](/p/graph/s/t/ENJUVIA-patent-expirations.png)
![Drug Sales Revenue Trends for ENJUVIA](/p/graph/drug-sales-revenues/ENJUVIA.png)
Recent Clinical Trials for ENJUVIA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Duramed Research | Phase 4 |
Duramed Research | Phase 3 |
US Patents and Regulatory Information for ENJUVIA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aspen | ENJUVIA | estrogens, conjugated synthetic b | TABLET;ORAL | 021443-001 | Dec 20, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Aspen | ENJUVIA | estrogens, conjugated synthetic b | TABLET;ORAL | 021443-005 | Apr 27, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Aspen | ENJUVIA | estrogens, conjugated synthetic b | TABLET;ORAL | 021443-002 | Dec 20, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Aspen | ENJUVIA | estrogens, conjugated synthetic b | TABLET;ORAL | 021443-003 | May 10, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Aspen | ENJUVIA | estrogens, conjugated synthetic b | TABLET;ORAL | 021443-004 | May 10, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ENJUVIA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Aspen | ENJUVIA | estrogens, conjugated synthetic b | TABLET;ORAL | 021443-003 | May 10, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Aspen | ENJUVIA | estrogens, conjugated synthetic b | TABLET;ORAL | 021443-003 | May 10, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Aspen | ENJUVIA | estrogens, conjugated synthetic b | TABLET;ORAL | 021443-001 | Dec 20, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Aspen | ENJUVIA | estrogens, conjugated synthetic b | TABLET;ORAL | 021443-005 | Apr 27, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Aspen | ENJUVIA | estrogens, conjugated synthetic b | TABLET;ORAL | 021443-002 | Dec 20, 2004 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ENJUVIA
See the table below for patents covering ENJUVIA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 4733701 | ⤷ Sign Up | |
Australia | 4541701 | ⤷ Sign Up | |
South Korea | 20070045364 | ⤷ Sign Up | |
European Patent Office | 1263770 | OESTROGENES STERO DIENS 6-OXYGENES A CYCLES A ET B AROMATIQUES (6-OXYGENATED STEROIDAL ESTROGENS WITH AROMATIC A AND B RINGS) | ⤷ Sign Up |
Germany | 60131253 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |